|
1.
|
MM ChidzongaL MahomvaSquamous cell
carcinoma of the oral cavity, maxillary antrum and lip in a
Zimbabwean population: a descriptive epidemiological studyOral
Oncol42184189200610.1016/j.oraloncology.2005.07.01116256417
|
|
2.
|
MM ChidzongaOral malignant neoplasia: a
survey of 428 cases in two Zimbabwean hospitalsOral
Oncol42177183200610.1016/j.oraloncology.2005.07.00316256412
|
|
3.
|
IW DimeryWK HongOverview of combined
modality therapies for head and neck cancerJ Natl Cancer
Inst8595111199310.1093/jnci/85.2.958418313
|
|
4.
|
SP SchantzGP YuHead and neck cancer
incidence trends in young Americans, 1973–1997, with a special
analysis for tongue cancerArch Otolaryngol Head Neck
Surg128268274200211886342
|
|
5.
|
CD LlewellynK LinklaterJ BellNW JohnsonKA
WarnakulasuriyaSquamous cell carcinoma of the oral cavity in
patients aged 45 years and under: a descriptive analysis of 116
cases diagnosed in the South East of England from 1990 to 1997Oral
Oncol39106114200312509963
|
|
6.
|
ME DudleyJR WunderlichPF RobbinsJC YangP
HwuDJ SchwartzentruberSL TopalianR SherryNP RestifoAM HubickiCancer
regression and autoimmunity in patients after clonal repopulation
with antitumor
lymphocytesScience298850854200210.1126/science.107651412242449
|
|
7.
|
S NégrierB EscudierF GomezJY DouillardA
RavaudC ChevreauM BuclonD PérolC LassetPrognostic factors of
survival and rapid progression in 782 patients with metastatic
renal carcinomas treated by cytokines: a report from the Groupe
Français d’ImmunothérapieAnn Oncol1314601468200212196373
|
|
8.
|
SA RosenbergProgress in human tumour
immunology and
immunotherapyNature411380384200110.1038/3507724611357146
|
|
9.
|
K BonifaceE GuignouardN PedrettiM GarciaA
DelwailFX BernardF NauG GuilletG DagregorioH YsselA role for T
cell-derived interleukin 22 in psoriatic skin inflammationClin Exp
Immunol150407415200710.1111/j.1365-2249.2007.03511.x17900301
|
|
10.
|
K WolkR SabatInterleukin-22: a novel T-
and NK-cell derived cytokine that regulates the biology of tissue
cellsCytokine Growth Factor
Rev17367380200610.1016/j.cytogfr.2006.09.00117030002
|
|
11.
|
S TrifariCD KaplanEH TranNK CrellinH
SpitsIdentification of a human helper T cell population that has
abundant production of interleukin 22 and is distinct from T(H)-17,
T(H)1 and T(H)2 cellsNat
Immunol10864871200910.1038/ni.177019578368
|
|
12.
|
K WolkS KunzE WitteM FriedrichK AsadullahR
SabatIL-22 increases the innate immunity of
tissuesImmunity21241254200410.1016/j.immuni.2004.07.00715308104
|
|
13.
|
D LejeuneL DumoutierS ConstantinescuW
KruijerJJ SchuringaJC RenauldInterleukin-22 (IL-22) activates the
JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma
cell line. Pathways that are shared with and distinct from IL-10J
Biol Chem2773367633682200210.1074/jbc.M20420420012087100
|
|
14.
|
S RadaevaR SunHN PanF HongB GaoInterleukin
22 (IL-22) plays a protective role in T cell-mediated murine
hepatitis: IL-22 is a survival factor for hepatocytes via STAT3
activationHepatology3913321342200410.1002/hep.2018415122762
|
|
15.
|
E ZieschéM BachmannH KleinertJ
PfeilschifterH MühlThe interleukin-22/STAT3 pathway potentiates
expression of inducible nitric-oxide synthase in human colon
carcinoma cellsJ Biol Chem2821600616015200717438334
|
|
16.
|
W ZhangY ChenH WeiC ZhengR SunJ ZhangZ
TianAntiapoptotic activity of autocrine interleukin-22 and
therapeutic effects of interleukin-22-small interfering RNA on
human lung cancer xenograftsClin Cancer
Res1464326439200810.1158/1078-0432.CCR-07-440118927282
|
|
17.
|
GF WeberFC GaertnerW ErlKP JanssenB
BlechertB HolzmannH WeighardtM EsslerIL-22-mediated tumor growth
reduction correlates with inhibition of ERK1/2 and AKT
phosphorylation and induction of cell cycle arrest in the G2-M
phaseJ
Immunol17782668272200610.4049/jimmunol.177.11.826617114505
|
|
18.
|
H NagakawaO ShimozatoL YuY TakiguchiK
TatsumiT KuriyamaM TagawaExpression of interleukin-22 in murine
carcinoma cells did not influence tumour growth in vivo but did
improve survival of the inoculated hostsScand J
Immunol60449454200410.1111/j.0300-9475.2004.01504.x15541036
|
|
19.
|
K MatsuoY IshibashiI KobayashiS OzekiM
OhishiT TangeJ HirataT KiyoshimaH SakaiNew human oral squamous
carcinoma cell line and its tumorigenic subline producing
granulocyte colony-stimulating factorJpn J Cancer
Res8512571262199410.1111/j.1349-7006.1994.tb02938.x7531680
|
|
20.
|
K TakahashiH KanazawaY AkiyamaS TasakiM
TakaharaT MutoH TanzawaK SatoEstablishment and characterization of
a cell line (SAS) from poorly differentiated human squamous cell
carcinoma of the tongueJ Jpn Stomatol Soc3820281989
|
|
21.
|
M MorifujiS TaniguchiH SakaiY NakabeppuM
OhishiDifferential expression of cytokeratin after orthotopic
implantation of newly established human tongue cancer cell lines of
defined metastatic abilityAm J
Pathol15613171326200010.1016/S0002-9440(10)65002-X
|
|
22.
|
JS YuanA ReedF ChenCN Stewart
JrStatistical analysis of real-time PCR dataBMC
Bioinformatics785200610.1186/1471-2105-7-8516504059
|
|
23.
|
K WolkE WitteE WallaceWD DockeS KunzK
AsadullahHD VolkW SterryR SabatIL-22 regulates the expression of
genes responsible for antimicrobial defense, cellular
differentiation, and mobility in keratinocytes: a potential role in
psoriasisEur J
Immunol3613091323200610.1002/eji.20053550316619290
|
|
24.
|
K BonifaceFX BernardM GarciaAL GurneyJC
LecronF MorelIL-22 inhibits epidermal differentiation and induces
proinflammatory gene expression and migration of human
keratinocytesJ
Immunol17436953702200510.4049/jimmunol.174.6.369515749908
|
|
25.
|
TL LeeJ YehC Van WaesZ ChenEpigenetic
modification of SOCS-1 differentially regulates STAT3 activation in
response to interleukin-6 receptor and epidermal growth factor
receptor signaling through JAK and/or MEK in head and neck squamous
cell carcinomasMol Cancer
Ther5819200610.1158/1535-7163.MCT-05-0069
|
|
26.
|
LH WeiML KuoCA ChenCH ChouWF ChengMC
ChangJL SuCY HsiehThe anti-apoptotic role of interleukin-6 in human
cervical cancer is mediated by up-regulation of Mcl-1 through a
PI3-K/Akt
pathwayOncogene2057995809200110.1038/sj.onc.120473311593385
|
|
27.
|
H ZhongJW SimonsDirect comparison of
GAPDH, beta-actin, cyclophilin, and 28S rRNA as internal standards
for quantifying RNA levels under hypoxiaBiochem Biophys Res
Commun259523526199910.1006/bbrc.1999.081510364451
|
|
28.
|
K HagiharaT NishikawaT IsobeJ SongY
SugamataK YoshizakiIL-6 plays a critical role in the synergistic
induction of human serum amyloid A (SAA) gene when stimulated with
proinflammatory cytokines as analyzed with an SAA isoform real-time
quantitative RT-PCR assay systemBiochem Biophys Res
Commun314363369200410.1016/j.bbrc.2003.12.096
|
|
29.
|
J VandesompeleK De PreterF PattynB PoppeN
Van RoyA De PaepeF SpelemanAccurate normalization of real-time
quantitative RT-PCR data by geometric averaging of multiple
internal control genesGenome
Biol30034200210.1186/gb-2002-3-7-research003412184808
|
|
30.
|
H KatoT TorigoeRadioimmunoassay for tumor
antigen of human cervical squamous cell
carcinomaCancer4016211628197710.1002/1097-0142(197710)40:4%3C1621::AID-CNCR2820400435%3E3.0.CO;2-I332328
|
|
31.
|
JM DukHW de BruijnKH GroenierH HollemaKA
ten HoorCancer of the uterine cervix: sensitivity and specificity
of serum squamous cell carcinoma antigen determinationsGynecol
Oncol39186194199010.1016/0090-8258(90)90430-S2227594
|
|
32.
|
JM DukKH GroenierHW de BruijnH HollemaKA
ten HoorAG van der ZeeJG AaldersPretreatment serum squamous cell
carcinoma antigen: a newly identified prognostic factor in
early-stage cervical carcinomaJ Clin Oncol1411111819968558185
|
|
33.
|
R MolinaX FilellaJM AugéR FuentesI BoverJ
RifaV MorenoE CanalsN ViñolasA MarquezTumor markers (CEA, CA 125,
CYFRA 21-1, SCC and NSE) in patients with non-small cell lung
cancer as an aid in histological diagnosis and prognosis.
Comparison with the main clinical and pathological prognostic
factorsTumour Biol24209218200310.1159/000074432
|
|
34.
|
Z ZhongZ WenJE Darnell JrStat3: a STAT
family member activated by tyrosine phosphorylation in response to
epidermal growth factor and
interleukin-6Science2649598199410.1126/science.81404228140422
|
|
35.
|
JJ SchuringaH SchepersE VellengaW
KruijerSer727-dependent transcriptional activation by association
of p300 with STAT3 upon IL-6 stimulationFEBS
Lett4957176200110.1016/S0014-5793(01)02354-711322950
|
|
36.
|
A WeberUR HenggeW BardenheuerI TischoffF
SommererA MarkwarthA DietzC WittekindA TannapfelSOCS-3 is
frequently methylated in head and neck squamous cell carcinoma and
its precursor lesions and causes growth
inhibitionOncogene2466996708200510.1038/sj.onc.1208818
|
|
37.
|
M Hernández-QuinteroW Kuri-HarcuchA
González RoblesF Castro-MuñozledoInterleukin-6 promotes human
epidermal keratinocyte proliferation and keratin cytoskeleton
reorganization in cultureCell Tissue Res3257790200616550359
|
|
38.
|
R EichnerP BonitzTT SunClassification of
epidermal keratins according to their immunoreactivity, isoelectric
point, and mode of expressionJ Cell
Biol9813881396198410.1083/jcb.98.4.13886201491
|
|
39.
|
E FuchsEpidermal differentiation: the bare
essentialsJ Cell
Biol11128072814199010.1083/jcb.111.6.28072269655
|
|
40.
|
RM PorterS LeitgebDW MeltonO SwenssonRA
EadyTM MaginGene targeting at the mouse cytokeratin 10 locus:
severe skin fragility and changes of cytokeratin expression in the
epidermisJ Cell Biol132925936199610.1083/jcb.132.5.9258603923
|
|
41.
|
E FuchsK WeberIntermediate filaments:
structure, dynamics, function, and diseaseAnnu Rev
Biochem63345382199410.1146/annurev.bi.63.070194.0020217979242
|
|
42.
|
E FuchsKeratins and the skinAnnu Rev Cell
Dev Biol11123153199510.1146/annurev.cb.11.110195.001011
|
|
43.
|
Y SuminamiS NagashimaA MurakamiS NawataT
GondoH HirakawaF NumaGA SilvermanH KatoSuppression of a squamous
cell carcinoma (SCC)-related serpin, SCC antigen, inhibits tumor
growth with increased intratumor infiltration of natural killer
cellsCancer Res6117761780200111280721
|
|
44.
|
K HashimotoT KiyoshimaK MatsuoS OzekiH
SakaiEffect of SCCA1 and SCCA2 on the suppression of
TNF-alpha-induced cell death by impeding the release of
mitochondrial cytochrome c in an oral squamous cell carcinoma cell
lineTumour Biol26165172200510.1159/00008694916006770
|
|
45.
|
ST AhmedJE Darnell JrSerpin B3/B4,
activated by STAT3, promote survival of squamous carcinoma
cellsBiochem Biophys Res
Commun378821825200910.1016/j.bbrc.2008.11.14719070595
|
